Adenosine A3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons

Drug Development Research

Volumn 40, Issue 3, 1997, Pages 267-273

  Sei, Yoshitatsu ^a   Von Lubitz, Dag K J E ^b   Abbracchio, Maria P ^c   Ji, Xiao Duo ^b   Jacobson, Kenneth A ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Adenosine receptors; Adenylate cyclase; Brain; Glutamic acid; Neurotoxicity; Nucleosides

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 N CYCLOPENTYLADENOSINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; BUCLADESINE; CYCLIC AMP; DIZOCILPINE; FORSKOLIN; GLUTAMIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CEREBELLUM; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; GRANULE CELL; IN VITRO STUDY; NEUROTOXICITY; NONHUMAN; RAT;

EID: 0030819798     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199703)40:3<267::AID-DDR7>3.0.CO;2-I     Document Type: Article

References (32)

1. 3 receptors in rat brain. Mol Pharmacol 48:1038-1045.
2. 3 receptor. Drug Dev Res 37:181.
3. Choi DW (1992): Excitotoxic cell death. J Neurobiol 9:1261-1276.
4. Dalziel HH, Westfall DP (1994): Receptors for adenine-nucleotides and nucleosides - subclassificution, distribution, and molecular characterization. Pharmacol Rev 46:449-166.
5. 1 receptor mediated responses in rat hippocampus. J Neurosci 17:607-614.
6. Fozard, JR, Pfannkuche HJ, Schuurman HJ (1996): Mast-cell degranulation following adenosine A(3) receptor activation in rats. Eur J Pharmacol 298:293-297.
7. Gallo V, Ciotti MT, Coletti A, Aloisi F, Levi G (1982): Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci USA 79:7919-7923.
8. 2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci 55:61-65.
9. 1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. J Neurochem 67:1921-1930.
10. Jacobson KA, Suzuki F (1997): Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors. Drug Dev Res 39:289-300.
11. Jacobson KA, von Lubitz DKJE, Daly JW, Fredholm BB (1996): Adenosine receptor ligands: Differences with acute and chronic treatment. Trends Pharmacol Sci 17:108-113.
12. 3-adenosine receptors. J Med Chem 37:3614-3621.
13. 3 receptor agonists. Biochem Biophys Res Commun 219:904-910. Correction: 1996, 221:849.
14. 2+]; and induces apoptosis. Drug Dev Res 37:182.
15. Knutsen LJS, Lau J, Petersen H, Thomsen C, Weis JU, Shalmi M, Judge ME, Hansen AJ, Sheardown MJ (1997): Novel neuroprotective adenosine agonists with diminished hypotensive effects. J Med Chem, in press.
16. 2A receptors. Trends Pharmacol Sci 17:364-372.
17. Phillis JW, Walter GA, O'Regan MH, Stair RE (1987): Increases in cerebral cortical perfusafe adenosine and inosine concentrations during hypoxia and ischemia. J Cereb Blood Flow Metab 7:679-686.
18. Phillis JW, Perkins LM, Smith-Barbour M, O'Regan MH (1995): Oxyparinol-enhanced postischemic recovery of the rat brain involves preservation of adeosine nucleotides. J Neurochem 64:2177-2184.
19. 3 AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
20. 3 adenosine receptors in rat basophilic leukemia (RBL-2H3) cells. J Immunol 154:5436-5443.
21. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB (1992): Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 13:439-445.
22. Siddiqi SM, Jacobson KA, Esker JL, Melman N, Tiwari KN, Secrist JA, Schneller SW, Cristalli G, Johnson CA, IJzerman AP (1995): Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. J Med Chem 38:1174-1188.
23. Stiles GL (1992): Adenosine receptors. J Biol Chem 267:6451-6454.
24. Stone TW, ed. (1995): CNS Neurotransmitters and Neuromodulators: Glutamate, Boca Raton, FL: CRC.
25. 3 receptor agonist 2-Cl-IB-MECA. Eur J Pharmacol 308:311-314.
26. von Lubitz DKJE, Dambrosia JM, Redmond DJ (1989): Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils. Neuroscience 2:451-157.
27. 1 receptor agonist and antagonist in cerebral ischemia. Eur J Pharmacol 256:161-167.
28. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67.
29. von Lubitz DKJE, Carter MF, Beenhakker M, Lin RC-S, Jacobson KA (1995a): Adenosine: A prototherapeutic concept in neurodegeneration. In Trambly B, Slikker B Jr (eds): Neuroprotective Agents: Clinical and Experimental Aspects. New York: Ann NY Acad Sci 765:163-178.
30. 2A receptor agonist and antagonist. Eur J Pharmacol 287:295-302.
31. von Lubitz DKJE, Lin R-C, Paul IA, Beenhakker M, Boyd M, Bischofberger N, Jacobson KA (1996): Postischemic administration of adenosine amine congener (ADAC): Analysis of recovery in gerbils. Eur J Pharmacol 316:171-179.
32. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436.